Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
about
The progress of angiogenic factors in the development of leukemiasMolecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Epigenetics in Cancer: A Hematological PerspectiveManagement of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Precision medicine for acute myeloid leukemiaEpigenetic modification suppresses proliferation, migration and invasion of urothelial cancer cell lines.TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesInhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic CellsNovel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility.Emerging biological therapies for the treatment of myelodysplastic syndromes.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.Mutation Analysis of Isocitrate Dehydrogenase (IDH1/2) and DNA Methyltransferase 3A (DNMT3A) in Thai Patients with Newly Diagnosed Acute Myeloid LeukemiaBNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine.Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock.Effects of Decitabine on the proliferation of K562 cells and the expression of DR4 gene.Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia.
P2860
Q26753835-18BC3346-A9EA-4F7E-AD91-6AA5410A02B6Q26801573-512C366C-9763-4A08-9463-C785C555C5D0Q28077082-E352B974-93E6-4C2B-9D40-B58F7C9CEF58Q30235355-E4CE42EF-18F9-4D65-B546-C83E5B0BF02BQ36934758-98446C64-F5A3-4A27-AAF5-218AC015D0BBQ37205264-63B43836-DB6D-48B2-8DF3-509B2991DCC6Q37566878-50A34474-F5B5-4EE0-94A0-0E006C10AD82Q37642044-E4E5ABE0-E2CD-4BD2-A473-406345A7C235Q38664735-C4CE933C-5B2A-44C8-BEB0-49A5EF246F19Q38703904-07FE2284-AFA6-4357-B078-F02A6AD05407Q38834981-45A539EF-A809-4BE8-896D-8A0C8CF3E25AQ38909048-DF3A0F71-C7AF-4F54-AB99-924D8B9AB9C3Q39430077-046FEBFA-EEB8-4BC3-9472-C11F7833930CQ40236553-BFE37784-A3A2-475A-8524-51C1720E8BD0Q42143971-FA4693D1-C7BA-4EF0-A0AE-460B222F6D55Q42362055-642119E3-D9C5-4B76-A523-EB0A2B25E803Q47562688-62980008-F9DD-441B-824B-53BE6C7FAB67Q50190216-7F388172-D222-4C9C-A4E3-7A7EF80BE5DAQ55261830-865F15FF-C380-46A2-A427-33A8D17A6128
P2860
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
@en
type
label
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
@en
prefLabel
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
@en
P2093
P2860
P1476
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
@en
P2093
Amer M Zeidan
Steven D Gore
Tae Kon Kim
P2860
P304
P356
10.1053/J.SEMINHEMATOL.2015.04.003
P577
2015-04-08T00:00:00Z